NEWS RSS FEED http://www.hdsa.org HDSA News © 2014 www.hdsa.org Auspex Announces Positive Topline Results From Registration Trial of SD-809 for Chorea Associated With Huntington's Disease http://www.hdsa.org/about/news-announcements-archive/auspex-press-release.html 5737 Wed, 17 Dec 2014 00:00:00 -0500 HDSA Now Accepting Applications for the 2015 Donald A. King Summer Research Fellowship http://www.hdsa.org/research/grant-applications/2015-donald-a-king-hdsa-summer-research-fellowship/index.html 5729 Wed, 10 Dec 2014 00:00:00 -0500 Huntington’s Disease Society of America awards Genea Biocells and Duke University collaborative grant http://medianet.com.au/releases/release-details.aspx?id=816392 5716 Thu, 04 Dec 2014 00:00:00 -0500 Marathon Team Raises 80K http://www.hdsa.org/about/news-announcements-archive/marathon-team-raises-80k.html 5693 Tue, 18 Nov 2014 00:00:00 -0500 HDBuzz: Huntington's disease clinical trial announcement: huntingtin-lowering drug to enter Phase I trial in 2015 http://www.hdsa.org/research/hdbuzz/index.html 5478 Tue, 04 Nov 2014 00:00:00 -0500 CREST-E Phase III Clinical Trial Stopped Early for Lack of Benefit http://www.hdsa.org/about/news-announcements-archive/crest-e-phase-iii-clinical-trial-stopped-early-for-lack-of.html 5650 Wed, 29 Oct 2014 00:00:00 -0400 Huntington’s Disease Society of America Announces 2014 HD Human Biology Project Grant Recipients http://www.hdsa.org/about/news-announcements-archive/huntington-s-disease-society-of-america-announces-2014-hd-human.html 5628 Tue, 21 Oct 2014 00:00:00 -0400 Auspex Pharmaceuticals Completes Enrollment in Phase 3 Clinical Trial of SD-809 in Chorea Associated With Huntington's Disease (FIRST-HD) http://investor.auspexpharma.com/releasedetail.cfm?ReleaseID=866632   5496 Wed, 20 Aug 2014 00:00:00 -0400 2CARE HD Clinical Trial Stopped Early for Lack of Benefit http://www.hdsa.org/about/news-announcements-archive/2care-hd-clinical-trial-stopped-early-for-lack-of-benefit.html 5476 Tue, 12 Aug 2014 00:00:00 -0400 Auspex Pharmaceuticals Announces Data From Interim Analysis of ARC-HD Switch Trial Demonstrating Clinical Activity of SD-809 http://www.marketwatch.com/story/auspex-pharmaceuticals-announces-data-from-interim-analysis-of-arc-hd-switch-trial-demonstrating-clinical-activity-of-sd-809-2014-06-23 Auspex Pharmaceuticals Announces Data From Interim Analysis of ARC-HD Switch Trial Demonstrating Clinical Activity of SD-809 LA JOLLA, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced results from a pre-specified interim subgroup analysis of the ongoing open-label ARC-HD Switch study in which the clinical experience of switching subjects' treatment from tetrabenazine to SD-809 was evaluated. The interim analysis was conducted to determine whether chorea control was maintained after converting subjects with Huntington's disease (HD) from stable doses of tetrabenazine to SD-809, which is administered in lower doses and with a simplified dosing regimen. In accordance with the pre-specified interim analysis plan, 12 subjects were included in the subgroup analysis, all of which had chorea assessed one week after switching from tetrabenazine to SD-809 and eight of which had chorea assessed four weeks after switching (the remaining four subjects had not yet reached the four-week point in the study at the time of the pre-specified interim analysis). At one and four weeks after switching to SD-809, the mean total chorea score decreased by approximately one point from baseline (week one change for 12 subjects was -0.83 +/-0.51 and week 4 change for eight subjects was -0.75 +/-0.75, mean and standard error), indicating that SD-809 maintained chorea control in these subjects. The conversion to SD-809 was generally well tolerated as no subject prematurely discontinued from the study, there were no adverse events of loss of chorea control and no serious adverse events were reported. "These data suggest that SD-809 is biologically active in these Huntington's disease patients and that switching to SD-809 was generally well tolerated," said David Stamler, M.D., Chief Medical Officer at Auspex. "The data give us confidence to complete the ongoing trials in HD as planned and to accelerate the development of SD-809 in other hyperkinetic movement disorders such as tardive dyskinesia and Tourette syndrome." The Principal Investigator of the SD-809 First-HD and ARC-HD Phase 3 clinical studies, Dr. Samuel Frank, M.D., Associate Professor of Neurology at the Boston University School of Medicine, said, "The interim analysis data from this small number of patients are very encouraging and provide the first indication that subjects can safely switch to SD-809 with at least equal control of chorea and other motor signs of Huntington's disease. These interim data support the continued evaluation of patients in the ARC-HD and the First-HD pivotal studies of SD-809." The adverse events reported to date in these interim analysis subjects during treatment with study drug were mild or moderate, with dry eye and dry mouth (one subject), fall (two subjects) and back pain (one subject), none of which were deemed related to study drug; and one subject with mood altered, deemed possibly related to study drug. The ARC-HD Switch study is ongoing and further assessments of safety, tolerability and chorea control in these and additional subjects will be made to confirm these interim findings. About ARC-HD Switch ARC-HD Switch is an open-label clinical trial in approximately 36 patients with chorea associated with Huntington's disease in which safety, tolerability and chorea control are assessed in subjects switching from stable doses of tetrabenazine to SD-809, which is administered in lower doses and with a simplified dosing regimen. The study aims to provide guidance to physicians on how to switch subjects' treatment from tetrabenazine to SD-809. The interim analysis was not designed to compare the safety and tolerability of SD-809 to tetrabenazine. Participating subjects are eligible to receive open-label SD-809 treatment in a one-year long-term safety study. Top-line data from all enrolled subjects in the ARC-HD Switch study are expected to be reported in the fourth quarter of 2014. This study is being conducted with the Huntington Study Group. More information about clinical trials evaluating SD-809 can be found at www.huntington-study-group.org or by calling 800-487-7671 . About Auspex Pharmaceuticals Auspex Pharmaceuticals is a late clinical stage biopharmaceutical company focused on the development and commercialization of novel medicines for the treatment of orphan diseases. Auspex's pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea associated with Huntington's disease, tardive dyskinesia and Tourette syndrome, as well as fibrotic indications, including idiopathic pulmonary fibrosis (IPF) and other orphan conditions. Auspex's lead product candidate, SD-809 (deutetrabenazine), is in a Phase 3 registration clinical trial for the treatment of chorea (abnormal involuntary movements) associated with Huntington's disease. Auspex has initiated a Phase 2/3 clinical trial of SD-809 in tardive dyskinesia and a Phase 1b study in Tourette syndrome. Auspex also plans to evaluate SD-560 (deuterium-containing form of pirfenidone) in a Phase 1 clinical trial. Auspex has employed its deuterium chemistry approach to optimize other compounds in its portfolio that are at various stages of development. For further information, please visit the company's website www.auspexpharma.com . 5350 Tue, 24 Jun 2014 00:00:00 -0400 Huntington’s Disease Society of America Launches First “HD News” App http://www.hdsa.org/about/news-announcements-archive/huntington-s-disease-society-of-america-launches-first-hd-news.html 5345 Fri, 20 Jun 2014 00:00:00 -0400 SGC and CHDI Foundation collaborate to discover new drug targets for Huntington's disease http://www.news-medical.net/news/20140606/SGC-and-CHDI-Foundation-collaborate-to-discover-new-drug-targets-for-Huntingtons-disease.aspx 5258 Fri, 06 Jun 2014 00:00:00 -0400 Pitt Study Demonstrates How Huntington’s Disease Protein Disrupts a Novel Cellular Pathway to Cause Death of Neurons http://www.hdsa.org/about/news-announcements-archive/pitt-study-demonstrates-how-huntington-s-disease-protein.html 5175 Mon, 19 May 2014 00:00:00 -0400 World leader in movement disorders Professor Ira Shoulson joins Prana Board http://www.hdsa.org/about/news-announcements-archive/world-leader-in-movement-disorders-professor-ira-shoulson-joins.html 5168 Wed, 14 May 2014 00:00:00 -0400 HDSA Appoints Director of Marketing & Communications http://www.hdsa.org/about/news-announcements-archive/huntington-s-disease-society-of-america-appoints-director-of.html 5123 Thu, 08 May 2014 00:00:00 -0400 Pride-HD Study Enrolling Patients Globally to Further Evaluate Pridopidine for the Symptomatic Treatment of Huntington’s Disease http://www.hdsa.org/about/news-announcements-archive/pride-hd-study-enrolling-patients-globally-to-further-evaluate.html 5035 Thu, 24 Apr 2014 00:00:00 -0400 Huntington’s Disease Society of America Announces Winners of the 2014 Donald A. King Summer Research Fellowship http://www.hdsa.org/about/news-announcements-archive/2014-donald-a-king-summer-research-fellowship.html 5028 Wed, 23 Apr 2014 00:00:00 -0400 Cleveland Clinic Online Health Chat- Understanding Huntington's Disease http://chat.clevelandclinic.org/chatpage.aspx?chatid=1642 5026 Tue, 22 Apr 2014 00:00:00 -0400 Save the Date: 8th Annual HD Clinical Research Symposium http://www.hdsa.org/events/12489/details.html 4938 Mon, 07 Apr 2014 00:00:00 -0400 Huntington's Disease Therapeutics Conference 2014: day 3 http://www.hdsa.org/research/hdbuzz/index.html 4825 Fri, 28 Mar 2014 00:00:00 -0400 HDSA Comments on Proposed SSA Neurological Listings http://www.hdsa.org/living-with-huntingtons/advocacy/hdsa-comments-on-proposed-ssa-neurological-listings.html 4929 Thu, 27 Mar 2014 00:00:00 -0400 Video Postcard from 2014 HD Therapeutics Conference http://www.hdsa.org/research/post-cards-from-palm-springs.html 4924 Wed, 26 Mar 2014 00:00:00 -0400 Huntington's Disease Therapeutics Conference 2014: day 2 http://www.hdsa.org/research/hdbuzz/index.html 4795 Thu, 27 Feb 2014 00:00:00 -0500 Huntington's Disease Therapeutics Conference 2014: day 1 http://www.hdsa.org/research/hdbuzz/index.html 4794 Wed, 26 Feb 2014 00:00:00 -0500 2014 FreezeHD Event a Success! http://www.hdsa.org/about/news-announcements-archive/freezehd-a-success.html 4787 Tue, 25 Feb 2014 00:00:00 -0500 The Huntington's Disease Society of America Endorses Enroll-HD http://www.hdsa.org/about/news-announcements-archive/hdsa-endorses-enroll-hd.html 4782 Fri, 21 Feb 2014 00:00:00 -0500 HDBUZZ: Prana announces results of Reach2HD trial of PBT2 for Huntington's disease http://www.hdsa.org/research/hdbuzz/index.html 4759 Thu, 20 Feb 2014 00:00:00 -0500 Raptor Pharmaceuticals Announces Phase 2/3 Clinical Trial Results with Cysteamine (RP103) in Huntington’s disease http://www.hdsa.org/research/news/raptor-pharmaceuticals-announces-phase-2-3-clinical-trial.html 4779 Thu, 20 Feb 2014 00:00:00 -0500 Prana Announces Results of REACH2HD Huntington Disease Trial http://www.hdsa.org/about/news-announcements-archive/prana-announces-results-of-reach2hd-huntington-disease-trial.html 4772 Tue, 18 Feb 2014 00:00:00 -0500 Results of Phase 2 HD prevention and biomarker study (PRECREST) using high-dose of creatine published http://www.hdsa.org/research/news/results-of-phase-2-hd-prevention-and-biomarker-study-precrest.html 4756 Mon, 10 Feb 2014 00:00:00 -0500 Omeros’ Huntington's Disease Drug Granted Fast-Track Status at the FDA http://www.hdsa.org/about/news-announcements-archive/omeros-huntington-s-disease-drug-granted-fast-track-status-at.html 4745 Wed, 05 Feb 2014 00:00:00 -0500 HDBuzz: Could a 'brain shuttle' get Huntington's disease drugs to where they're needed? http://www.hdsa.org/research/hdbuzz/index.html 4658 Mon, 20 Jan 2014 00:00:00 -0500 HDBuzz: Is a new Huntington’s disease drug study on the right Trk? http://www.hdsa.org/research/hdbuzz/index.html 4649 Thu, 02 Jan 2014 00:00:00 -0500 NIH announces first funding opportunities for the BRAIN Initiative! http://www.hdsa.org/research/news/nih-announces-first-funding-opportunities-for-the-brain.html 4663 Wed, 18 Dec 2013 00:00:00 -0500 HDBuzz:A study looking for links between diet and symptom onset in Huntington's disease has unexpectedly found that people who developed symptoms earlier tended to consumed more dairy products http://www.hdsa.org/research/hdbuzz/index.html 4584 Wed, 27 Nov 2013 00:00:00 -0500 Mental Health Parity Final Regulation Update http://www.hdsa.org/living-with-huntingtons/advocacy/healthcare-reform-advocacy/mental-health-parity.html 4602 Wed, 20 Nov 2013 00:00:00 -0500 HD Buzz: New study sheds light on regional degeneration in HD http://www.hdsa.org/research/hdbuzz/index.html 4583 Tue, 12 Nov 2013 00:00:00 -0500 HD Insights Volume 5 Now Available http://www.hdsa.org/research/hd-insights.html 4566 Wed, 06 Nov 2013 00:00:00 -0500 HDBuzz: Buzzilia Video: Day 3 http://www.hdsa.org/research/hdbuzz/index.html 4363 Mon, 28 Oct 2013 00:00:00 -0400 test news http://www.hdsa.org/new-to-hd-1/index.html TEST 4510 Tue, 15 Oct 2013 00:00:00 -0400 Videos from 2013 HD world Congress https://vimeo.com/album/2556826 4501 Thu, 10 Oct 2013 00:00:00 -0400 Huntington’s Disease Society of America Announces First-Ever HD Human Biology Project Awards http://www.hdsa.org/about/news-announcements-archive/huntington-s-disease-society-of-america-announces-first-ever-hd.html 4485 Thu, 03 Oct 2013 00:00:00 -0400 HDSA named Champion for Coverage by U.S. Department of Health & Human Services http://www.hdsa.org/about/in-the-news/hdsa-named-champions-for-coverage-by-u-s-department-of-health.html 4482 Tue, 01 Oct 2013 00:00:00 -0400 November 9, 2013 HSG Huntington Disease Clinical Research Symposium http://www.hdsa.org/events/12137/details.html 4337 Tue, 01 Oct 2013 00:00:00 -0400 7 Run NYC ING Marathon for HD http://www.hdsa.org/about/news-announcements-archive/7-run-nyc-ing-marathon-for-hd.html 4448 Fri, 20 Sep 2013 00:00:00 -0400 'Buzzilia' from the Huntington's Disease World Congress: day 3 http://www.hdsa.org/research/hdbuzz/index.html 4441 Wed, 18 Sep 2013 00:00:00 -0400 'Buzzilia' from the Huntington's Disease World Congress: day 2 http://www.hdsa.org/research/hdbuzz/index.html 4435 Tue, 17 Sep 2013 00:00:00 -0400 'Buzzilia' from the Huntington's Disease World Congress: day 1 http://www.hdsa.org/research/hdbuzz/index.html 4434 Mon, 16 Sep 2013 00:00:00 -0400 2013 World Congress on Huntington's disease - September 15-18 in Rio de Janeiro, Brazil https://www.hdsa.org/events/12136/details.html 2013 World Congress on Huntington's disease to be held in Rio de Janeiro, Brazil 4336 Thu, 08 Aug 2013 00:00:00 -0400 HDSA Reports Data Breach http://www.hdsa.org/about/news-announcements-archive/hdsa-reports-data-breach.html 4333 Tue, 06 Aug 2013 00:00:00 -0400 HDSA Donald A. King Summer Research Fellow Jolene Luther http://www.hdsa.org/about/news-announcements-archive/hdsa-donald-a-king-summer-research-fellow-jolene-luther.html 4292 Thu, 25 Jul 2013 00:00:00 -0400 Prana Completes Phase 2 Huntington Disease Trial with PBT2 http://www.hdsa.org/research/news/pranacompletes.html 4255 Tue, 23 Jul 2013 00:00:00 -0400 HDSA Research News: New clues to why striatal neurons are preferentially damaged in HD http://www.hdsa.org/about/news-announcements-archive/new-clues-to-why-striatal-neurons.html 4248 Sun, 21 Jul 2013 00:00:00 -0400 HDBuzz: Can sad mice help treat Huntington's disease? https://www.hdsa.org/research/hdbuzz/index.html 4224 Wed, 17 Jul 2013 00:00:00 -0400 HDBuzz: Gene Silencing Drug Safe in ALS Patients http://www.hdsa.org/research/hdbuzz/gene-silencing-drug-safe-in-als-patients.html 4197 Mon, 01 Jul 2013 00:00:00 -0400 New Phase III Trial First-HD http://www.hdsa.org/research/clinical-trials/first-hd-phase-iii-trial-of-slow-releasing-form-of-tetrabenazine.html 4147 Wed, 12 Jun 2013 00:00:00 -0400 HDBuzz DNA Repair Modifies Long CAG Tracts in HD http://www.hdsa.org/research/hdbuzz/hdbuz-dna-repair-modifies-long-cag-tracts-in-hd.html 4133 Mon, 03 Jun 2013 00:00:00 -0400 Omeros Reports Phase I OMS824 Results Positive http://www.hdsa.org/research/news/omeros-phase-i-oms824-tril-results-positive.html 4129 Fri, 31 May 2013 00:00:00 -0400 Pharmacological Treatment of Chorea in Huntington’s Disease– Good Clinical Practice versus Evidence-based Guideline http://www.hdsa.org/research/news/pharmacological-treatment-of-chorea-in-hd-clinical-practice.html 4077 Fri, 17 May 2013 00:00:00 -0400 HDBuzz: Landmark Study puts HD trials on TRACK http://www.hdsa.org/research/hdbuzz/hdbuzz-landmark-study-puts-hd-trials-on-track.html 4029 Thu, 09 May 2013 00:00:00 -0400 HDBuzz: Splicing with Danger http://www.hdsa.org/research/hdbuzz/hdbuzz-splicing-with-danger.html 4024 Tue, 07 May 2013 00:00:00 -0400 Donald A. King Fellowships Summer 2013 Awarded /research/grant-applications/don-king-fellowship-for-2013-awarded.html 3573 Mon, 06 May 2013 00:00:00 -0400 May is Huntington's Disease Awareness Month https://www.hdsa.org/how-you-can-help/may-is-hd-awareness-month-2013/index.html 4003 Wed, 01 May 2013 00:00:00 -0400 April 30-Last Day for the HDSA Annual Convention Early Bird Rate http://www.hdsa.org/living-with-huntingtons/national-convention/index.html 3990 Tue, 30 Apr 2013 00:00:00 -0400 ASO treatment delivered to ALS patients in Phase 1 study http://www.hdsa.org/research/news/aso-treatment-delivered-to-als-patients-in-phase-1-study.html 3993 Tue, 30 Apr 2013 00:00:00 -0400 HDSA Annual Convention Early Bird Rate Deadline April 30, 2013 http://www.hdsa.org/living-with-huntingtons/national-convention/convention/index.html 3976 Fri, 26 Apr 2013 00:00:00 -0400 HDBuzz: Is Access to Genetic Testing a Problem? http://www.hdsa.org/research/hdbuzz/hdbuzz-is-access-to-genetic-testing-a-problem.html 3965 Tue, 23 Apr 2013 00:00:00 -0400 Potential Changes to Long Term Care Insurance Underwriting Standards http://www.hdsa.org/living-with-huntingtons/family-care/living-at-risk/potential-changes-to-long-term-care-insurance-underwriting.html 3945 Tue, 16 Apr 2013 00:00:00 -0400 HD Insights Volume 4 Now Available http://www.hdsa.org/research/hd-insights.html 3940 Mon, 15 Apr 2013 00:00:00 -0400 FDA Selects HD for Patient-Focused Drug Development http://www.hdsa.org/research/news/fda-selects-hd-for-patient-focused-drug-development.html 3933 Fri, 12 Apr 2013 00:00:00 -0400 Felix Austria! http://www.hdsa.org/living-with-huntingtons/felix-austria.html 3931 Thu, 11 Apr 2013 00:00:00 -0400 HDBuzz: Major Roche-Isis deal http://www.hdsa.org/research/hdbuzz/hdbuzz-major-roche-isis-deal.html 3923 Tue, 09 Apr 2013 00:00:00 -0400 HDBuzz: Lost in translation http://www.hdsa.org/research/hdbuzz/hdbuzz-lost-in-translation.html 3915 Mon, 08 Apr 2013 00:00:00 -0400 Roche and ISIS Form HD Alliance http://www.hdsa.org/research/news/roche-and-isis-form-hd-alliance.html 3919 Mon, 08 Apr 2013 00:00:00 -0400 HDBuzz: Rules for a Good Sleep http://www.hdsa.org/research/hdbuzz/hdbuzz-rules-for-a-good-sleep.html 3860 Mon, 25 Mar 2013 00:00:00 -0400 HDBuzz: New Genetic Testing Technique http://www.hdsa.org/research/hdbuzz/hdbuzz-new-genetic-testing-technique.html 3854 Mon, 18 Mar 2013 00:00:00 -0400 HDBuzz: New Testing Technique 3853 Mon, 18 Mar 2013 00:00:00 -0400 HDBuzz: No surprises in published results from HART study of Huntexil for Huntington's disease http://www.hdsa.org/research/hdbuzz/hdbuzz-no-surprises-in-published-hart-results.html 3838 Tue, 12 Mar 2013 00:00:00 -0400 In Memoriam- Eva Weissman http://www.hdsa.org/about/news-announcements-archive/in-memoriam-eva-weissman.html 3823 Wed, 06 Mar 2013 00:00:00 -0500 Auspex Announces New Phase III Trial for Chorea http://www.hdsa.org/research/news/auspex-plans-phase-iii-clinical-trial-for-chorea-in-hd.html 3791 Thu, 28 Feb 2013 00:00:00 -0500 NIH Director Francis Collins on HD and Rare Disease Day http://directorsblog.nih.gov/making-this-a-land-for-you-and-me/ 3786 Thu, 28 Feb 2013 00:00:00 -0500 HD Buzz: The 'N17' region of huntingtin protein: an address label in Huntington's disease? http://www.hdsa.org/research/hdbuzz/hdbuzz-n17-region-of-huntingtin.html 3773 Tue, 26 Feb 2013 00:00:00 -0500 Join HDSA in Washington DC this April http://www.hdsa.org/about/news-announcements-archive/hdsaindc.html 3711 Thu, 07 Feb 2013 00:00:00 -0500 HDBuzz and Sleep https://www.hdsa.org/research/hdbuzz/hdbuzz-hd-and-slaap.html 3707 Wed, 06 Feb 2013 00:00:00 -0500 UNO has not discovered a cure for HD http://www.hdsa.org/research/hdbuzz/uno-has-not-discovered-a-cure-for-hd.html 3663 Tue, 29 Jan 2013 00:00:00 -0500 HDBUZZ: Prana Biotech Publishes Animal Data http://www.hdsa.org/research/hdbuzz/hdbuzz-prana-biotech-publishes-animal-data.html 3631 Mon, 14 Jan 2013 00:00:00 -0500 HD Buzz: 'Guard dog' proteins reveal surprising connections between Hd and other brain disorders http://www.hdsa.org/research/hdbuzz/hd-buzz-guard-dog-proteins.html 3625 Thu, 10 Jan 2013 00:00:00 -0500 IRA Charitable Rollover Reinstated http://www.hdsa.org/about/news-announcements-archive/ira-charitable-rollover-reinstated.html 3621 Tue, 08 Jan 2013 00:00:00 -0500 2013 Annual Convention http://www.hdsa.org/living-with-huntingtons/national-convention/convention/index.html Announcing the 28th Annual Convention in Jacksonville, FL 3612 Fri, 04 Jan 2013 00:00:00 -0500 New HDSA Scientific Advisory Board Convenes to start Research Program planning http://www.hdsa.org/research/scientific-advisory-board/index.html 3599 Wed, 19 Dec 2012 00:00:00 -0500 HDSA Advocates Succeed in having Adult-Onset HD added to SSA Compassionate Allowance Listing http://www.hdsa.org/about/news-announcements-archive/ssa-adds-adult-onset-hd-to-the-compassionate-allowance-list.html http://www.hdsa.org/about/news-announcements-archive/ssa-adds-adult-onset-hd-to-the-compassionate-allowance-list.html 3574 Fri, 07 Dec 2012 00:00:00 -0500 HDBUZZ: Targeting oxidative stress in Huntington's disease http://www.hdsa.org/research/hdbuzz/targeting-oxidative-stress-in-huntington-s-disease.html http://www.hdsa.org/research/hdbuzz/targeting-oxidative-stress-in-huntington-s-disease.html 3575 Wed, 05 Dec 2012 00:00:00 -0500 New Specialty Care Facility for people with HD Opens in Minnesota http://www.hdsa.org/about/news-announcements-archive/new-facility-with-30-hd-beds-opens.html http://www.hdsa.org/about/news-announcements-archive/new-facility-with-30-hd-beds-opens.html 3576 Sat, 01 Dec 2012 00:00:00 -0500